文章摘要

维得利珠单抗治疗炎症性肠病的短期疗效与安全性分析:单中心真实世界研究

作者: 1姚嘉茵, 1彭翔, 1刘涛, 1赵俊章, 1张敏, 1胡品津, 1郅敏
1 中山大学附属第六医院消化内科,广州 510655
通讯: 郅敏 Email: zhimin@mail.sysu.edu.cn

Short-term efficacy and safety of vedolizumab in the treatment of inflammatory bowel disease: A single-center real-world study

Authors: 1YAO Jiayin, 1PENG Xiang, 1LIU Tao, 1ZHAO Junzhang, 1ZHANG Min, 1HU Pinjin, 1ZHI Min
1 Department of Gastroenterology, Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510655, China

CorrespondingAuthor: ZHI Min Email: zhimin@mail.sysu.edu.cn